Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...

Two of Pfizer’s former top executives have pitched at least four of its directors, including chief executive Albert Bourla, on activist investor Starboard Value’s plan for turning around the ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla ... leadership – the breast cancer drug Ibrance has ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Activist investor Starboard Value has taken a stake of about US$1bil in Pfizer Inc and is seeking to spur a turnaround of the ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

Companies with high dividend yields can seem attractive, but there is far more to income stocks than above-average yields.

Activist investor Starboard Value has taken a stake of about US$1 billion in Pfizer and is seeking to spur a turnaround of ...